Researchers are preparing to launch an unprecedented trial to protect people exposed to Ebola in the DRC and Uganda
Home
News
ScienceInsider
‘That could be a game changer’: an antiviral pill gets first test for Ebola prevention
Back To ScienceInsider
New Ebola Vaccine Could Help With Rapidly Spreading Outbreak (Live Updates)
First patient recovers from Ebola but WHO warns of 'huge' death rate | The National
Ebola vaccine from Oxford Covid team nears production for trials - Businessday NG
Merck weighs use of COVID antiviral Lagevrio as Ebola outbreak worsens: report
WHO Identifies Potential Ebola Therapies, Vaccines to Test in Outbreak
Better diagnostics could have limited this Ebola outbreak
Race for Ebola vaccine gets $50m boost as medics struggle to trace contacts | The National
Which vaccines will curb the Ebola outbreak? WHO debates
Scientists target human trials for new Ebola vaccine 'within months'
Daily briefing: What it will take to stop the spiralling Ebola outbreak
Past outbreaks spawned clever strategies for testing antivirals and antibodies, but researchers will still face major challenges…
The vaccine, which hasn’t been tested on humans, would be the first capable of treating the deadly Bundibugyo strain of Ebola.
Testing, sequencing, and clinical trial efforts spring to life as Bundibugyo virus spreads
Small monkey experiments raise some hopes—and many questions
Existing vaccines may offer some protection against the rare strain now circulating—but the evidence is scant
Clinical trials for treatments against Ebola Bundibugyo virus are ‘in a strong position’ to be launched quickly in the Democratic…
